2026 Connecticut Legislative Priorities

2026 CONNECTICUT Legislative Priorities

Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Connecticut residents impacted by cancer and their leadership is vital to defeating this disease. In 2026 the American Cancer Society Cancer Action Network (ACS CAN) will work with the Connecticut General Assembly on legislative and regulatory efforts that provide affordable, adequate access to health insurance including Medicaid, ensure adequate funding for lifesaving cancer screening and prevention programs, and enact prevention policies to protect kids from tobacco products and help support those who are trying to quit. We will be making the following fact-based policies a priority and ask for your support:

Ensuring Access to Quality Care

· Medicaid Defense: The preservation of eligibility, coverage, and access to Medicaid remains critically important for many low-income state residents who depend on the program for cancer and chronic disease prevention, as well as early detection, diagnostic, and treatment services. ACS CAN will work to ensure Medicaid enrollees have adequate access and coverage and will oppose proposals that create barriers or reduce access to care for cancer patients, survivors, and those who could be diagnosed with cancer.

· Affordable, Adequate Health Insurance: ACS CAN will advocate for policies that ensure access to quality, affordable and comprehensive health insurance including Medicaid and will support efforts to curb the availability of inadequate health plans.

· Patient Navigation: Patient navigation is the individualized assistance offered to patients, families, and caregivers to help overcome health care system barriers and facilitate timely access to quality health and psychosocial care. ACS CAN supports policies to increase access to patient navigation services across the cancer continuum and ensure coverage by both public and private payers.

Cancer Prevention and Early Detection

· Breast and Cervical Cancer: ACS CAN will advocate to maintain funding of $2.5 million for the Connecticut Breast and Cervical Cancer Early Detection Program (BCCEDP) the state breast and cervical cancer screening and treatment program for low-income uninsured and underinsured women administered by the Connecticut Department of Health.

· Colorectal Cancer: ACS CAN will work to maintain funding for colorectal cancer screening, treatment, and patient navigation programs

· Prostate Cancer: ACS CAN will advocate for policies that improve prostate cancer screening rates and reduce disparities. This includes policies that would give men at high-risk for prostate cancer improved access to prostate cancer screening by requiring health insurance coverage for evidence-based prostate cancer preventive care and screenings, without cost sharing.

· Lung Cancer: ACS CAN advocates for all insurance plans, including traditional Medicaid, to provide a comprehensive benefit for lung cancer screening including all follow-up testing according to recommended guidelines, without enrollee cost sharing or other barriers.

· HPV: ACS CAN supports legislation to increase uptake of the HPV vaccine including policies to strengthen school vaccination requirements, facilitate pharmacists’ ability to administer vaccines to children, and appropriate funding for HPV vaccine education and administration.

Reducing the Toll of Tobacco

· Tobacco Taxes: As Connecticut works to identify funding strategies to fund critical programs, including tobacco control, ACS CAN will advocate to increase the cigarette tax by $1.00 per pack with a parallel tax on all other tobacco products including cigars, e-cigarettes, Electronic Nicotine Delivery Systems (ENDS), vape products, synthetic nicotine products and nicotine pouches.

· Tobacco Prevention and Cessation Funding: ACS CAN will work to maintain $12 million in annual funding for fact-based, statewide tobacco prevention and cessation programs.

· Access to Tobacco Cessation: ACS CAN will advocate for all insurance plans, including the state Medicaid program, to maintain a comprehensive cessation benefit that covers individual, group, and telephone counseling and all FDA-approved tobacco cessation medications without cost-sharing or other barriers to accessing care.

· Menthol Cigarettes and All Other Flavored Tobacco Products: ACS CAN supports legislation to end the sale of menthol cigarettes and all other flavored tobacco products. Comprehensive policies to end the sale of flavored tobacco products must include all tobacco products, all flavors, and all tobacco retailers.

For more information, contact:

Bryte Johnson, Connecticut Government Relations Director, ACS CAN

[email protected] | Phone: 916-712-8619

ACS CAN is making cancer a top priority for public officials and candidates at the federal, state, and local levels. ACS CAN empowers advocates across the country to make their voices heard and influence evidence-based public policy change as well as legislative and regulatory solutions that will reduce the cancer burden. As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN is critical to the fight for a world without cancer. For more information, please visit www.fightcancer.org.